Alimera Sciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations" section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s commitment to retina specialists and their patients is manifest in Alimera’s product and development portfolio designed to treat early-and late-stage diseases. For more information, please visit www.alimerasciences.com.
For press inquiries:
Katie Brazelfor Alimera Sciences404-317-8361 email@example.com For investor inquiries: CG Capitalfor Alimera Sciences877-889-1972 firstname.lastname@example.org